Search All News
Data scientists from Columbia University and around the world are starting to use the world’s electronic health records and databases to identify the best therapies for treating COVID-19 patients.
Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus.
Patients taking the recommended diuretic for hypertension experienced more potentially serious side effects than those taking a similar drug, according to a new study from Columbia researchers.
Non-medical cannabis use—including frequent or problematic use—is more common in adults with pain than in those without pain, a new study from Columbia University Irving Medical Center has found.
- January 3, 2020
Some compounds found in many personal care products displace natural fat-like molecules in skin cells, which may explain how they cause an allergic skin rash.
- December 18, 2019
Columbia scientists have captured the first images of a new gene editing tool that could improve upon existing CRISPR-based tools.
- December 3, 2019
With new microneedles in development at Columbia University, delivering precise doses of drugs to the inner ear without risking permanent hearing damage may soon be possible.
- November 27, 2019
The first-ever detailed images of a malaria protein, a key modulator of drug resistance, show how the parasite evades antimalarials—and may help scientists find ways to restore the drugs’ potency.
- November 14, 2019
A new study finds that cognitive impairment begins in the earliest stages of age-related hearing loss—when hearing is still considered normal.
- November 1, 2019
A new study from Columbia University found that a higher level of education protected against cognitive decline in black people with a gene linked to Alzheimer’s disease.
- October 21, 2019
Columbia University researchers have captured new images of a temperature-sensing molecule in its open, intermediate, and closed states.